Theriva Historical Balance Sheet

TOVX Stock

USD 1.47 0.15 9.26%

Trend analysis of Theriva Biologics balance sheet accounts such as Cash of 28 M, Non Current Assets Total of 33.6 M, Cash And Short Term Investments of 28 M or Liabilities And Stockholders Equity of 66.7 M provides information on Theriva Biologics' total assets, liabilities, and equity, which is the actual value of Theriva Biologics to its prevalent stockholders. By breaking down trends over time using Theriva Biologics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Theriva Biologics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Theriva Biologics is a good buy for the upcoming year.

Theriva Biologics Inventory

(197,505)

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Theriva Stock please use our How to Invest in Theriva Biologics guide.

About Theriva Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Theriva Biologics at a specified time, usually calculated after every quarter, six months, or one year. Theriva Biologics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Theriva Biologics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Theriva currently owns. An asset can also be divided into two categories, current and non-current.

Theriva Biologics Balance Sheet Chart

At this time, Theriva Biologics' Other Current Liabilities is fairly stable compared to the past year. Property Plant And Equipment Net is likely to rise to about 2.6 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 4.2 M in 2025.

Total Current Liabilities Net Debt Accounts Payable Non Current Assets Total Net Working Capital

Add Fundamental

Total Current Liabilities

Total Current Liabilities is an item on Theriva Biologics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Theriva Biologics are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Accounts Payable

An accounting item on the balance sheet that represents Theriva Biologics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Theriva Biologics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Non Current Assets Total

The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.

Most accounts from Theriva Biologics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Theriva Biologics current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theriva Biologics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.

For more information on how to buy Theriva Stock please use our How to Invest in Theriva Biologics guide.At this time, Theriva Biologics' Other Current Liabilities is fairly stable compared to the past year. Property Plant And Equipment Net is likely to rise to about 2.6 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 4.2 M in 2025.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	7.1M	6.7M	7.7M	4.2M
Total Assets	71.9M	55.2M	63.5M	66.7M

Total Current Liabilities Total Assets

Theriva Biologics balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Other Stockholder Equity	Total Liab	Total Current Assets	Other Current Liab	Property Plant And Equipment Net	Non Currrent Assets Other	Inventory	Other Current Assets	Short Long Term Debt Total	Short Term Debt	Net Receivables	Non Current Liabilities Total	Short Term Investments	Intangible Assets	Common Stock	Common Stock Shares Outstanding	Good Will
Total Assets		0.15	0.95	-0.73	-0.77	-0.02	0.83	0.79	0.83	0.88	0.53	0.87	0.2	0.86	-0.43	-0.79	0.64	0.92	0.62	0.59	0.62	-0.36	0.46	-0.33	0.44	0.77
Total Current Liabilities	0.15		-0.11	-0.14	-0.23	0.73	0.13	0.03	0.13	0.16	0.76	0.19	0.97	0.15	-0.12	0.03	0.3	0.07	0.07	-0.02	0.12	-0.3	0.26	0.07	-0.14	0.02
Total Stockholder Equity	0.95	-0.11		-0.77	-0.7	-0.19	0.86	0.68	0.86	0.81	0.23	0.87	-0.06	0.75	-0.38	-0.78	0.51	0.85	0.49	0.51	0.43	-0.3	0.38	-0.35	0.57	0.67
Net Debt	-0.73	-0.14	-0.77		0.54	-0.01	-0.98	-0.16	-0.98	-0.54	-0.2	-0.96	-0.13	-0.38	0.39	0.5	-0.19	-0.49	0.04	0.04	-0.15	0.31	-0.29	0.05	-0.79	-0.15
Retained Earnings	-0.77	-0.23	-0.7	0.54		-0.14	-0.62	-0.63	-0.62	-0.95	-0.54	-0.64	-0.22	-0.79	0.34	0.84	-0.63	-0.74	-0.58	-0.5	-0.56	0.51	-0.57	0.51	-0.36	-0.61
Accounts Payable	-0.02	0.73	-0.19	-0.01	-0.14		-0.01	-0.14	-0.01	0.05	0.5	0.08	0.62	-0.02	0.0	0.18	0.16	-0.14	-0.09	-0.16	-0.02	-0.23	0.2	0.0	-0.14	-0.15
Cash	0.83	0.13	0.86	-0.98	-0.62	-0.01		0.32	1.0	0.66	0.28	0.99	0.14	0.53	-0.37	-0.59	0.32	0.61	0.1	0.13	0.27	-0.33	0.35	-0.11	0.77	0.3
Non Current Assets Total	0.79	0.03	0.68	-0.16	-0.63	-0.14	0.32		0.32	0.79	0.56	0.37	0.12	0.9	-0.33	-0.7	0.72	0.89	0.95	0.87	0.79	-0.21	0.36	-0.43	-0.08	1.0
Cash And Short Term Investments	0.83	0.13	0.86	-0.98	-0.62	-0.01	1.0	0.32		0.66	0.28	0.99	0.14	0.53	-0.37	-0.59	0.32	0.61	0.1	0.13	0.27	-0.33	0.35	-0.11	0.77	0.3
Other Stockholder Equity	0.88	0.16	0.81	-0.54	-0.95	0.05	0.66	0.79	0.66		0.57	0.69	0.2	0.92	-0.29	-0.87	0.74	0.86	0.69	0.68	0.65	-0.47	0.58	-0.5	0.36	0.77
Total Liab	0.53	0.76	0.23	-0.2	-0.54	0.5	0.28	0.56	0.28	0.57		0.35	0.79	0.63	-0.28	-0.34	0.63	0.52	0.55	0.43	0.73	-0.33	0.41	-0.12	-0.14	0.55
Total Current Assets	0.87	0.19	0.87	-0.96	-0.64	0.08	0.99	0.37	0.99	0.69	0.35		0.21	0.57	-0.37	-0.62	0.39	0.65	0.17	0.19	0.29	-0.37	0.4	-0.15	0.73	0.35
Other Current Liab	0.2	0.97	-0.06	-0.13	-0.22	0.62	0.14	0.12	0.14	0.2	0.79	0.21		0.23	-0.09	-0.01	0.37	0.14	0.14	0.09	0.18	-0.27	0.28	0.07	-0.14	0.11
Property Plant And Equipment Net	0.86	0.15	0.75	-0.38	-0.79	-0.02	0.53	0.9	0.53	0.92	0.63	0.57	0.23		-0.17	-0.76	0.76	0.92	0.78	0.84	0.76	-0.31	0.46	-0.36	0.23	0.89
Non Currrent Assets Other	-0.43	-0.12	-0.38	0.39	0.34	0.0	-0.37	-0.33	-0.37	-0.29	-0.28	-0.37	-0.09	-0.17		0.34	0.08	-0.27	-0.33	0.14	-0.35	0.08	-0.05	0.18	0.02	-0.34
Inventory	-0.79	0.03	-0.78	0.5	0.84	0.18	-0.59	-0.7	-0.59	-0.87	-0.34	-0.62	-0.01	-0.76	0.34		-0.51	-0.8	-0.63	-0.61	-0.51	0.41	-0.49	0.46	-0.44	-0.69
Other Current Assets	0.64	0.3	0.51	-0.19	-0.63	0.16	0.32	0.72	0.32	0.74	0.63	0.39	0.37	0.76	0.08	-0.51		0.74	0.7	0.74	0.57	-0.54	0.67	-0.53	-0.04	0.7
Short Long Term Debt Total	0.92	0.07	0.85	-0.49	-0.74	-0.14	0.61	0.89	0.61	0.86	0.52	0.65	0.14	0.92	-0.27	-0.8	0.74		0.79	0.79	0.69	-0.41	0.52	-0.46	0.26	0.88
Short Term Debt	0.62	0.07	0.49	0.04	-0.58	-0.09	0.1	0.95	0.1	0.69	0.55	0.17	0.14	0.78	-0.33	-0.63	0.7	0.79		0.83	0.74	-0.25	0.39	-0.54	-0.32	0.95
Net Receivables	0.59	-0.02	0.51	0.04	-0.5	-0.16	0.13	0.87	0.13	0.68	0.43	0.19	0.09	0.84	0.14	-0.61	0.74	0.79	0.83		0.61	-0.2	0.38	-0.39	-0.06	0.87
Non Current Liabilities Total	0.62	0.12	0.43	-0.15	-0.56	-0.02	0.27	0.79	0.27	0.65	0.73	0.29	0.18	0.76	-0.35	-0.51	0.57	0.69	0.74	0.61		-0.15	0.27	-0.17	-0.1	0.78
Short Term Investments	-0.36	-0.3	-0.3	0.31	0.51	-0.23	-0.33	-0.21	-0.33	-0.47	-0.33	-0.37	-0.27	-0.31	0.08	0.41	-0.54	-0.41	-0.25	-0.2	-0.15		-0.96	0.79	-0.11	-0.18
Intangible Assets	0.46	0.26	0.38	-0.29	-0.57	0.2	0.35	0.36	0.35	0.58	0.41	0.4	0.28	0.46	-0.05	-0.49	0.67	0.52	0.39	0.38	0.27	-0.96		-0.82	0.09	0.34
Common Stock	-0.33	0.07	-0.35	0.05	0.51	0.0	-0.11	-0.43	-0.11	-0.5	-0.12	-0.15	0.07	-0.36	0.18	0.46	-0.53	-0.46	-0.54	-0.39	-0.17	0.79	-0.82		0.16	-0.42
Common Stock Shares Outstanding	0.44	-0.14	0.57	-0.79	-0.36	-0.14	0.77	-0.08	0.77	0.36	-0.14	0.73	-0.14	0.23	0.02	-0.44	-0.04	0.26	-0.32	-0.06	-0.1	-0.11	0.09	0.16		-0.1
Good Will	0.77	0.02	0.67	-0.15	-0.61	-0.15	0.3	1.0	0.3	0.77	0.55	0.35	0.11	0.89	-0.34	-0.69	0.7	0.88	0.95	0.87	0.78	-0.18	0.34	-0.42	-0.1

Click cells to compare fundamentals

Theriva Biologics Account Relationship Matchups

Theriva Biologics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	8.4M	70.4M	71.9M	55.2M	63.5M	66.7M
Total Current Liabilities	3.0M	3.6M	7.1M	6.7M	7.7M	4.2M
Total Stockholder Equity	8.0M	65.4M	54.6M	39.7M	45.7M	47.9M
Net Debt	(5.8M)	(65.8M)	(40.1M)	(21.0M)	(18.9M)	(18.0M)
Retained Earnings	(248.1M)	(271.3M)	(291.0M)	(309.3M)	(278.4M)	(264.5M)
Accounts Payable	886K	524K	915K	770K	885.5K	1.1M
Cash	6.2M	67.3M	41.8M	23.2M	26.7M	28.0M
Non Current Assets Total	476K	1.5M	26.3M	27.8M	32.0M	33.6M
Cash And Short Term Investments	6.2M	67.3M	41.8M	23.2M	26.7M	28.0M
Liabilities And Stockholders Equity	8.4M	70.4M	71.9M	55.2M	63.5M	66.7M
Other Stockholder Equity	240.8M	336.6M	343.5M	346.2M	398.2M	418.1M
Total Liab	3.2M	5.0M	17.3M	15.5M	17.9M	18.7M
Total Current Assets	7.9M	68.9M	45.5M	27.4M	31.5M	33.1M
Other Current Liab	1.8M	2.9M	5.7M	5.4M	6.2M	6.5M
Property Plant And Equipment Net	453K	1.5M	1.5M	2.2M	2.5M	2.6M
Other Current Assets	768K	1.1M	1.2M	2.3M	2.6M	2.8M
Short Long Term Debt Total	473K	1.5M	1.7M	2.2M	1.9M	1.9M
Short Term Debt	287K	124K	489K	550K	495K	529.4K
Non Current Liabilities Total	186K	1.4M	10.2M	8.8M	10.1M	10.6M
Common Stock	29K	132K	16K	18K	16.2K	15.4K
Common Stock Shares Outstanding	1.9M	12.2M	613.1K	644.3K	740.9K	1.1M
Net Tangible Assets	(2.9M)	(7.2M)	65.4M	46.3M	53.3M	55.9M
Net Invested Capital	(7.2M)	65.4M	52.1M	37.2M	42.8M	28.6M
Capital Stock	15.3M	132K	2.8M	2.8M	2.5M	2.4M
Net Working Capital	5.0M	65.3M	38.5M	20.7M	23.8M	30.6M
Property Plant Equipment	786K	453K	1.5M	1.5M	1.8M	1.1M
Capital Lease Obligations	473K	1.5M	1.4M	1.9M	2.2M	1.3M
Property Plant And Equipment Gross	1.5M	1.5M	2.4M	3.2M	3.7M	2.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Theriva Stock Analysis

When running Theriva Biologics' price analysis, check to measure Theriva Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theriva Biologics is operating at the current time. Most of Theriva Biologics' value examination focuses on studying past and present price action to predict the probability of Theriva Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theriva Biologics' price. Additionally, you may evaluate how the addition of Theriva Biologics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Theriva Historical Balance Sheet

Theriva Biologics Inventory

(197,505)

About Theriva Balance Sheet Analysis

Theriva Biologics Balance Sheet Chart

Total Current Liabilities

Net Debt

Accounts Payable

Non Current Assets Total

Theriva Biologics balance sheet Correlations

Theriva Biologics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Theriva Biologics balance sheet Accounts

Also Currently Popular

Additional Tools for Theriva Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Good Will	+ 1.0	Non Current Assets Total
Total Current Assets	+ 0.99	Cash
Total Current Assets	+ 0.99	Cash And Short Term Investments
Other Current Liab	+ 0.97	Total Current Liabilities
Total Stockholder Equity	+ 0.95	Total Assets

Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Intangible Assets	- 0.96	Short Term Investments
Total Current Assets	- 0.96	Net Debt
Other Stockholder Equity	- 0.95	Retained Earnings
Inventory	- 0.87	Other Stockholder Equity